{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T06:38:00Z","timestamp":1790318280411,"version":"4.1.0"},"reference-count":166,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T00:00:00Z","timestamp":1631059200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Vet. Sci."],"abstract":"<jats:p>Peste des petits ruminants virus (PPRV) is a virus that mainly infects goats and sheep causing significant economic loss in Africa and Asia, but also posing a serious threat to Europe, as recent outbreaks in Georgia (2016) and Bulgaria (2018) have been reported. In order to carry out the eradication of PPRV, an objective set for 2030 by the Office International des Epizooties (OIE) and the Food and Agriculture Organization of the United Nations (FAO), close collaboration between governments, pharmaceutical companies, farmers and researchers, among others, is needed. Today, more than ever, as seen in the response to the SARS-CoV2 pandemic that we are currently experiencing, these goals are feasible. We summarize in this review the current vaccination approaches against PPRV in the field, discussing their advantages and shortfalls, as well as the development and generation of new vaccination strategies, focusing on the potential use of adenovirus as vaccine platform against PPRV and more broadly against other ruminant pathogens.<\/jats:p>","DOI":"10.3389\/fvets.2021.729879","type":"journal-article","created":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T01:26:11Z","timestamp":1631064371000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["A New Look at Vaccine Strategies Against PPRV Focused on Adenoviral Candidates"],"prefix":"10.3389","volume":"8","author":[{"given":"Jos\u00e9 M.","family":"Rojas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noem\u00ed","family":"Sevilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,9,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1099\/vir.0.025841-0","article-title":"Global distribution of peste des petits ruminants virus and prospects for improved diagnosis and control","volume":"91","author":"Banyard","year":"2010","journal-title":"J Gen Virol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.vetmic.2012.12.013","article-title":"Peste des petits ruminants, the next eradicated animal disease?","volume":"165","author":"Albina","year":"2013","journal-title":"Vet Microbiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/01652176.2020.1714096","article-title":"Peste des petits ruminants in large ruminants, camels and unusual hosts","volume":"40","author":"Rahman","year":"2020","journal-title":"Vet Q."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1007\/s11250-018-1623-6","article-title":"Peste des petits ruminants in wild ungulates","volume":"50","author":"ul-Rahman","year":"2018","journal-title":"Trop Anim Health Prod."},{"key":"B5","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00284-016-1030-z","article-title":"Detection of Peste Des Petits Ruminants Virus (PPRV) genome from nasal swabs of dogs","volume":"73","author":"Ratta","year":"2016","journal-title":"Curr Microbiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"673","DOI":"10.7589\/0090-3558-46.2.673","article-title":"Seroprevalance of peste des petits ruminants (PPR) in goitered gazelle (gazella subgutturosa subgutturosa) in Turkey","volume":"46","author":"G\u00fcr","year":"2010","journal-title":"J Wildl Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.tvjl.2005.08.020","article-title":"Evaluation of the virulence of some strains of peste-des-petits-ruminants virus (PPRV) in experimentally infected West African dwarf goats","volume":"173","author":"Couacy-Hymann","year":"2007","journal-title":"Vet J."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1017\/S0950268809991592","article-title":"Peste des petits ruminants in Arabian wildlife","volume":"138","author":"Kinne","year":"2010","journal-title":"Epidemiol Infect."},{"key":"B9","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/j.1439-0450.2004.00731.x","article-title":"Severe PPR infection in gazelles kept under semi-free range conditions","volume":"51","author":"Abu Elzein","year":"2004","journal-title":"J Vet Med Ser B Infect Dis Vet Public Heal."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.3201\/eid1912.130973","article-title":"Peste des petits ruminants infection among cattle and wildlife in northern Tanzania","volume":"19","author":"Lembo","year":"2013","journal-title":"Emerg Infect Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1136\/vr.121.19.443","article-title":"An outbreak of peste des petits ruminants in a zoological collection","volume":"121","author":"Furley","year":"1987","journal-title":"Vet Rec."},{"key":"B12","doi-asserted-by":"publisher","first-page":"516","DOI":"10.7589\/0090-3558-12.4.516","article-title":"Response of white-tailed deer to infection with peste des petits ruminants virus","volume":"12","author":"Hamdy","year":"1976","journal-title":"J Wildl Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1099\/0022-1317-74-4-631","article-title":"Characterization of morbilliviruses isolated from dolphins and porpoises in Europe","volume":"74","author":"Visser","year":"1993","journal-title":"J Gen Virol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1006\/viro.1993.1217","article-title":"Dolphin and porpoise morbilliviruses are genetically distinct from phocine distemper virus","volume":"193","author":"Barrett","year":"1993","journal-title":"Virology."},{"key":"B15","doi-asserted-by":"publisher","first-page":"5435","DOI":"10.1073\/pnas.1119972109","article-title":"Feline morbillivirus, a previously undescribed paramyxovirus associated with tubulointerstitial nephritis in domestic cats","volume":"109","author":"Woo","year":"2012","journal-title":"Proc Natl Acad Sci USA."},{"key":"B16","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/ncomms1796","article-title":"Bats host major mammalian paramyxoviruses","volume":"3","author":"Drexler","year":"2012","journal-title":"Nat Commun."},{"key":"B17","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3201\/eid0601.000107","article-title":"Molecular genetic evidence of a novel morbillivirus in a long-finned pilot whale (Globicephalus melas)","volume":"6","author":"Taubenberger","year":"2000","journal-title":"Emerg Infect Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s13337-015-0281-9","article-title":"Peste des petits ruminants vaccine and vaccination in India: sharing experience with disease endemic countries","volume":"26","author":"Singh","year":"2015","journal-title":"VirusDisease."},{"key":"B19","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s11259-015-9638-1","article-title":"Immunization of sheep with DNA coding for the variable region of anti-idiotypic antibody generates humoral and cell mediated immune responses specific for peste des petits ruminants virus","volume":"39","author":"Apsana","year":"2015","journal-title":"Vet Res Commun."},{"key":"B20","doi-asserted-by":"publisher","first-page":"4922","DOI":"10.1016\/j.vaccine.2007.04.005","article-title":"Immunization of mice with DNA coding for the variable regions of anti-idiotypic antibody generates antigen-specific response","volume":"25","author":"Vani","year":"2007","journal-title":"Vaccine."},{"key":"B21","doi-asserted-by":"publisher","first-page":"3870","DOI":"10.1016\/S0264-410X(01)00127-X","article-title":"Recombinant hemagglutinin protein of rinderpest virus expressed in insect cells induces humoral and cell mediated immune responses in cattle","volume":"19","author":"Sinnathamby","year":"2001","journal-title":"Vaccine."},{"key":"B22","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.virol.2003.08.022","article-title":"Baculovirus display of fusion protein of Peste des petits ruminants virus and hemagglutination protein of Rinderpest virus and immunogenicity of the displayed proteins in mouse model","volume":"317","author":"Rahman","year":"2003","journal-title":"Virology."},{"key":"B23","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.vetimm.2010.12.007","article-title":"Immune responses to hemagglutinin-neuraminidase protein of peste des petits ruminants virus expressed in transgenic peanut plants in sheep","volume":"140","author":"Khandelwal","year":"2011","journal-title":"Vet Immunol Immunopathol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jviromet.2014.11.018","article-title":"Peste des petits ruminants virus-like particles induce both complete virus-specific antibodies and virus neutralizing antibodies in mice","volume":"213","author":"Liu","year":"2015","journal-title":"J Virol Methods."},{"key":"B25","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.micpath.2017.03.021","article-title":"M protein is sufficient for assembly and release of Peste des petits ruminants virus-like particles","volume":"107","author":"Wang","year":"2017","journal-title":"Microb Pathog."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e104791","DOI":"10.1371\/journal.pone.0104791","article-title":"Self-assembly and release of peste des petits ruminants virus-like particles in an insect cell-baculovirus system and their immunogenicity in mice and goats","volume":"9","author":"Li","year":"2014","journal-title":"PLoS ONE."},{"key":"B27","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3389\/fmicb.2020.00609","article-title":"Virus-like particles derived from a virulent strain of pest des petits ruminants virus elicit a more vigorous immune response in mice and small ruminants than those from a vaccine strain","volume":"11","author":"Yan","year":"2020","journal-title":"Front Microbiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1297-9716-43-48","article-title":"Rescue of recombinant peste des petits ruminants virus: Creation of a GFP-expressing virus and application in rapid virus neutralization test","volume":"43","author":"Hu","year":"2012","journal-title":"Vet Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1297-9716-45-62","article-title":"Induction of protective immune response against both PPRV and FMDV by a novel recombinant PPRV expressing FMDV VP1","volume":"45","author":"Yin","year":"2014","journal-title":"Vet Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.vaccine.2014.10.050","article-title":"Rescue of a vaccine strain of peste des petits ruminants virus: In vivo evaluation and comparison with standard vaccine","volume":"33","author":"Muniraju","year":"2015","journal-title":"Vaccine."},{"key":"B31","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s12088-010-0026-9","article-title":"recombinants expressing the fusion and hemagglutinin genes of PPRV protects goats against virulent challenge","volume":"50","author":"Chandran","year":"2010","journal-title":"Indian J Microbiol."},{"key":"B32","unstructured":"Differential effects of viral vectors on migratory afferent lymph dendritic cells in vitro predict enhanced immunogenicity in vivo938594 Cubillos-ZapataC GuzmanE TurnerA GilbertSC PrenticeH HopeJC 10.1128\/JVI.05127-1121752909J Virol852011"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0037170","article-title":"A novel recombinant peste des petits ruminants-canine adenovirus vaccine elicits long-lasting neutralizing antibody response against ppr in goats","volume":"7","author":"Qin","year":"2012","journal-title":"PLoS ONE."},{"key":"B34","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.vetimm.2011.11.014","article-title":"Adenovirus-based oral vaccine for rabbit hemorrhagic disease","volume":"145","author":"Wang","year":"2012","journal-title":"Vet Immunol Immunopathol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"101226","DOI":"10.1371\/journal.pone.0101226","article-title":"Vaccination with recombinant adenoviruses expressing the peste des petits ruminants virus F or H proteins overcomes viral immunosuppression and induces protective immunity against PPRV challenge in sheep","volume":"9","author":"Rojas","year":"2014","journal-title":"PLoS ONE."},{"key":"B36","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13567-016-0306-4","article-title":"Determination of the minimum fully protective dose of adenovirus-based DIVA vaccine against peste des petits ruminants virus challenge in East African goats","volume":"47","author":"Holzer","year":"2016","journal-title":"Vet Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1297-9716-45-24","article-title":"Recombinant adenovirus expressing the haemagglutinin of peste des petits ruminants virus (PPRV) protects goats against challenge with pathogenic virus; A DIVA vaccine for PPR","volume":"45","author":"Herbert","year":"2014","journal-title":"Vet Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/0264-410X(95)80008-2","article-title":"Protection of goats against peste des petits ruminants with recombinant capripoxviruses expressing the fusion and haemagglutinin protein genes of rinderpest virus","volume":"13","author":"Romero","year":"1995","journal-title":"Vaccine."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1128\/JVI.77.2.1571-1577.2003","article-title":"Development of a dual recombinant vaccine to protect small ruminants against peste-des-petits-ruminants virus and capripoxvirus infections","volume":"77","author":"Berhe","year":"2003","journal-title":"J Virol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"4742","DOI":"10.1016\/j.vaccine.2010.04.102","article-title":"goat poxvirus-vectored peste-des-petits-ruminants vaccine induces long-lasting neutralization antibody to high levels in goats and sheep","volume":"28","author":"Chen","year":"2010","journal-title":"Vaccine."},{"key":"B41","doi-asserted-by":"publisher","first-page":"3772","DOI":"10.1016\/j.vaccine.2014.05.025","article-title":"Protective efficacy of a single immunization with capripoxvirus-vectored recombinant peste des petits ruminants vaccines in presence of pre-existing immunity","volume":"32","author":"Caufour","year":"2014","journal-title":"Vaccine."},{"key":"B42","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.virol.2017.11.015","article-title":"Comparative evaluation of three capripoxvirus-vectored peste des petits ruminants vaccines","volume":"514","year":"2018","journal-title":"Virology."},{"key":"B43","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3389\/fimmu.2018.00421","article-title":"Bovine herpesvirus-4-based vector delivering Peste des Petits Ruminants Virus hemagglutinin ORF induces both neutralizing antibodies and cytotoxic T cell responses","volume":"9","author":"Macchi","year":"2018","journal-title":"Front Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3390\/vaccines8020205","article-title":"A novel recombinant Newcastle disease virus vectored DIVA vaccine against peste des petits ruminants in goats","volume":"8","author":"Murr","year":"2020","journal-title":"Vaccines."},{"key":"B45","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1159\/000149044","article-title":"Classification of peste des petits ruminants virus as the fourth member of the genus morbillivirus","volume":"11","author":"Gibbs","year":"1979","journal-title":"Intervirology."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1093\/emboj\/21.10.2364","article-title":"Polyploid measles virus with hexameric genome length","volume":"21","author":"Rager","year":"2002","journal-title":"EMBO J."},{"key":"B47","doi-asserted-by":"publisher","first-page":"708","DOI":"10.3201\/eid0807.010471","article-title":"Prevalence, distribution, and host range of Peste des petits ruminants virus, Turkey","volume":"8","author":"\u00d6zkul","year":"2002","journal-title":"Emerg Infect Dis."},{"key":"B48","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/0168-1702(96)01312-3","article-title":"Geographic distribution and epidemiology of peste des petits ruminants viruses","volume":"43","author":"Shaila","year":"1996","journal-title":"Virus Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1103\/PhysRevLett.64.1613","article-title":"Self-organized critical state of sandpile automaton models","volume":"64","author":"Dhar","year":"1990","journal-title":"Phys Rev Lett."},{"key":"B50","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.vetmic.2014.08.031","article-title":"Molecular characterisation of lineage IV peste des petits ruminants virus using multi gene sequence data","volume":"174","author":"Senthil Kumar","year":"2014","journal-title":"Vet Microbiol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.3201\/eid1707.101216","article-title":"Asian lineage of peste des petits ruminants virus, Africa","volume":"17","author":"Kwiatek","year":"2011","journal-title":"Emerg Infect Dis."},{"key":"B52","doi-asserted-by":"publisher","first-page":"321","DOI":"10.19182\/remvt.7128","article-title":"Adaptation du virus de la peste des petits ruminants aux cultures cellulaires : notes pr\u00e9liminaires","volume":"15","author":"Gilbert","year":"1962","journal-title":"Rev d'\u00e9levage m\u00e9decine v\u00e9t\u00e9rinaire des pays Trop."},{"key":"B53","doi-asserted-by":"publisher","first-page":"23","DOI":"10.19182\/remvt.8885","article-title":"Pathogenicity of attenuated peste des petits ruminants virus in sheep and goats","volume":"43","author":"Adu","year":"1990","journal-title":"Rev Elev Med Vet Pays Trop."},{"key":"B54","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.cimid.2008.12.003","article-title":"Virological and antigenic characterization of two Peste des Petits Ruminants (PPR) vaccine viruses of Indian origin","volume":"33","author":"Singh RP De","year":"2010","journal-title":"Comp Immunol Microbiol Infect Dis."},{"key":"B55","doi-asserted-by":"crossref","first-page":"311","DOI":"10.19182\/remvt.8771","article-title":"Attenuation of a strain of rinderpest virus: potential homologous live vaccine","volume":"42","author":"Diallo","year":"1989","journal-title":"Rev Elev Med Vet Pays Trop."},{"key":"B56","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3390\/vaccines8020168","article-title":"Comparison of immunogenicity and protective efficacy of PPR live attenuated vaccines (Nigeria 75\/1 and sungri 96) administered by intranasal and subcutaneous routes","volume":"8","author":"Mahapatra","year":"2020","journal-title":"Vaccines."},{"key":"B57","doi-asserted-by":"publisher","first-page":"e01471","DOI":"10.1128\/JVI.01471-18","article-title":"Comparison of the immunogenicities and cross-lineage efficacies of live attenuated peste des petits ruminants virus vaccines PPRV\/Nigeria\/75\/1 and PPRV\/Sungri\/96","volume":"92","author":"Hodgson","year":"2018","journal-title":"J Virol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1586\/erv.10.74","article-title":"Vaccines against peste des petits ruminants virus","volume":"9","author":"Sen","year":"2010","journal-title":"Expert Rev Vaccines."},{"key":"B59","doi-asserted-by":"publisher","first-page":"5591","DOI":"10.1016\/j.vaccine.2007.02.013","article-title":"The threat of peste des petits ruminants: progress in vaccine development for disease control","volume":"25","author":"Diallo","year":"2007","journal-title":"Vaccine."},{"key":"B60","first-page":"101","article-title":"Preliminary results on innocuity and immunogenicity of an inactivated vaccine against Peste des petits ruminants","volume":"52","author":"Ronchi","year":"2016","journal-title":"Vet Ital."},{"key":"B61","doi-asserted-by":"publisher","first-page":"e447","DOI":"10.1111\/tbed.12314","article-title":"Evaluation of humoral response and protective efficacy of an inactivated vaccine against peste des petits ruminants virus in goats","volume":"63","author":"Cosseddu","year":"2016","journal-title":"Transbound Emerg Dis."},{"key":"B62","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jviromet.2015.09.001","article-title":"suicidal DNA vaccine expressing the fusion protein of peste des petits ruminants virus induces both humoral and cell-mediated immune responses in mice","volume":"225","author":"Wang","year":"2015","journal-title":"J Virol Methods."},{"key":"B63","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.jviromet.2013.07.031","article-title":"Immune responses in mice vaccinated with a suicidal DNA vaccine expressing the hemagglutinin glycoprotein from the peste des petits ruminants virus","volume":"193","author":"Wang","year":"2013","journal-title":"J Virol Methods."},{"key":"B64","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1111\/j.1365-2567.2006.02519.x","article-title":"Maintenance of antigen-specific immunological memory through variable regions of heavy and light chains of anti-idiotypic antibody","volume":"120","author":"Vani","year":"2007","journal-title":"Immunology."},{"key":"B65","doi-asserted-by":"publisher","first-page":"4816","DOI":"10.1016\/S0264-410X(01)00210-9","article-title":"Immune responses in goats to recombinant hemagglutinin-neuraminidase glycoprotein of Peste des petits ruminants virus: identification of a T cell determinant","volume":"19","author":"Sinnathamby","year":"2001","journal-title":"Vaccine."},{"key":"B66","doi-asserted-by":"publisher","first-page":"918","DOI":"10.3390\/v11100918","article-title":"Peste des petits Ruminants virus-like particles induce a potent humoral and cellular immune response in goats","volume":"11","author":"Yan","year":"2019","journal-title":"Viruses."},{"key":"B67","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.virusres.2007.01.015","article-title":"Reverse genetics for peste-des-petits-ruminants virus (PPRV): promoter and protein specificities","volume":"126","author":"Bailey","year":"2007","journal-title":"Virus Res."},{"key":"B68","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.vaccine.2013.11.033","article-title":"Two replication-defective adenoviral vaccine vectors for the induction of immune responses to PPRV","volume":"32","author":"Rojas","year":"2014","journal-title":"Vaccine."},{"key":"B69","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.4161\/hv.28974","article-title":"Enhancing poxvirus vectors vaccine immunogenicity","volume":"10","author":"Garc\u00eda-Arriaza","year":"2014","journal-title":"Hum Vaccines Immunother."},{"key":"B70","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1080\/14760584.2018.1522255","article-title":"Poxvirus-based vector systems and the potential for multi-valent and multi-pathogen vaccines","volume":"17","author":"Prow","year":"2018","journal-title":"Expert Rev Vaccines."},{"key":"B71","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/0264-410X(93)90386-C","article-title":"Protection of goats against peste des petits ruminants with a vaccinia virus double recombinant expressing the F and H genes of rinderpest virus","volume":"11","author":"Jones","year":"1993","journal-title":"Vaccine."},{"key":"B72","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0166-0934(01)00419-0","article-title":"Potential of bovine herpesvirus 4 as a gene delivery vector","volume":"101","author":"Donofrio","year":"2002","journal-title":"J Virol Methods."},{"key":"B73","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.vaccine.2010.11.048","article-title":"Swine adipose stromal cells loaded with recombinant bovine herpesvirus 4 virions expressing a foreign antigen induce potent humoral immune responses in pigs","volume":"29","author":"Donofrio","year":"2011","journal-title":"Vaccine."},{"key":"B74","doi-asserted-by":"publisher","first-page":"e52758","DOI":"10.1371\/journal.pone.0052758","article-title":"Clinical protection of goats against CpHV-1 induced genital disease with a BoHV-4-based vector expressing CpHV-1 gD","volume":"8","author":"Donofrio","year":"2013","journal-title":"PLoS ONE."},{"key":"B75","doi-asserted-by":"publisher","first-page":"705539","DOI":"10.3389\/fimmu.2021.705539","article-title":"Immunization with Bovine Herpesvirus-4-Based vector delivering PPRV H protein protects sheep from challenge with PPRV","volume":"12","author":"Rodr\u00edguez-Mart\u00edn","year":"2021","journal-title":"Front Immunol."},{"key":"B76","unstructured":"The COVID-19 Candidate Vaccine Landscape and Tracker2021"},{"key":"B77","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.ymthe.2004.07.013","article-title":"Adenoviruses as vaccine vectors","volume":"10","author":"Tatsis","year":"2004","journal-title":"Mol Ther."},{"key":"B78","doi-asserted-by":"publisher","first-page":"5368","DOI":"10.1016\/j.vaccine.2008.08.001","article-title":"Efficacy and safety of a live canine adenovirus-vectored rabies virus vaccine in swine","volume":"26","author":"Liu","year":"2008","journal-title":"Vaccine."},{"key":"B79","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1089\/hum.2005.16.281","article-title":"Good manufacturing practice production of adenoviral vectors for clinical trials","volume":"16","author":"Lusky","year":"2005","journal-title":"Hum Gene Ther."},{"key":"B80","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/0042-6822(88)90302-9","article-title":"A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5","volume":"163","author":"McGrory","year":"1988","journal-title":"Virology."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1038\/sj.gt.3301301","article-title":"Production of first generation adenovirus vectors: a review","volume":"7","author":"Danthinne","year":"2000","journal-title":"Gene Ther."},{"key":"B82","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/978-3-642-79496-4_13","article-title":"E3 transcription unit of adenovirus","volume":"199","author":"Wold","year":"1995","journal-title":"Curr Top Microbiol Immunol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/S0952-7915(99)80064-8","article-title":"Immune responses to adenoviruses: viral evasion mechanisms and their implications for the clinic","volume":"11","author":"Wold","year":"1999","journal-title":"Curr Opin Immunol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1089\/hum.1994.5.10-1217","article-title":"Prolonged transgene expression in cotton rat lung with recombinant adenoviruses defective in E2a","volume":"5","author":"Engelhardt","year":"1994","journal-title":"Hum Gene Ther."},{"key":"B85","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1128\/JVI.72.3.2022-2032.1998","article-title":"In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1\/E2A, or E1\/E4 deleted","volume":"72","author":"Lusky","year":"1998","journal-title":"J Virol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.2741\/1607","article-title":"Adenovirus vectors deleted for genes essential for viral DNA replication","volume":"10","author":"Schaack","year":"2005","journal-title":"Front Biosci."},{"key":"B87","doi-asserted-by":"publisher","first-page":"8459","DOI":"10.1128\/jvi.70.12.8459-8467.1996","article-title":"Molecular characterization of replication-competent variants of adenovirus vectors and genome modifications to prevent their occurrence","volume":"70","author":"Hehir","year":"1996","journal-title":"J Virol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1002\/bit.24342","article-title":"Preventing spontaneous genetic rearrangements in the transgene cassettes of adenovirus vectors","volume":"109","author":"Cottingham","year":"2012","journal-title":"Biotechnol Bioeng."},{"key":"B89","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1006\/viro.1996.0088","article-title":"Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis","volume":"217","author":"Fisher","year":"1996","journal-title":"Virology."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1128\/jvi.71.3.1842-1849.1997","article-title":"Construction of adenovirus vectors through Cre-lox recombination","volume":"71","author":"Hardy","year":"1997","journal-title":"J Virol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"7835","DOI":"10.1128\/JVI.73.9.7835-7841.1999","article-title":"Improved production of gutted adenovirus in cells expressing adenovirus preterminal protein and DNA polymerase","volume":"73","author":"Hartigan-O'Connor","year":"1999","journal-title":"J Virol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"137","DOI":"10.2217\/14796694.2.1.137","article-title":"Current developments in adenovirus-based cancer gene therapy","volume":"2","author":"Rein","year":"2006","journal-title":"Futur Oncol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"e11815","DOI":"10.1371\/journal.pone.0011815","article-title":"HIV antigen incorporation within adenovirus hexon hypervariable 2 for a novel HIV vaccine approach","volume":"5","author":"Matthews","year":"2010","journal-title":"PLoS One."},{"key":"B94","doi-asserted-by":"publisher","first-page":"5301","DOI":"10.1016\/j.vaccine.2007.05.024","article-title":"Experimental immunization of cats with a recombinant rabies-canine adenovirus vaccine elicits a long-lasting neutralizing antibody response against rabies","volume":"25","author":"Hu","year":"2007","journal-title":"Vaccine."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.micinf.2005.11.007","article-title":"Prevention of rabies virus infection in dogs by a recombinant canine adenovirus type-2 encoding the rabies virus glycoprotein","volume":"8","author":"Hu","year":"2006","journal-title":"Microbes Infect."},{"key":"B96","doi-asserted-by":"publisher","first-page":"e3548","DOI":"10.1371\/journal.pone.0003548","article-title":"Nasal delivery of an adenovirus-based vaccine bypasses pre-existing immunity to the vaccine carrier and improves the immune response in mice","volume":"3","author":"Croyle","year":"2008","journal-title":"PLoS ONE."},{"key":"B97","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/BF01317147","article-title":"Oral rabies vaccination of skunks and foxes with a recombinant human adenovirus vaccine","volume":"123","author":"Charlton","year":"1992","journal-title":"Arch Virol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/1074-7613(94)90074-4","article-title":"MHC class I-cestricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses","volume":"1","author":"Yang","year":"1994","journal-title":"Immunity."},{"key":"B99","first-page":"137","article-title":"Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo","volume":"3","author":"Yang","year":"1996","journal-title":"Gene Ther"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1073\/pnas.92.5.1401","article-title":"Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression","volume":"92","author":"Dai","year":"1995","journal-title":"Proc Natl Acad Sci USA."},{"key":"B101","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1099\/0022-1317-36-1-59","article-title":"Characteristics of a human cell line transformed by DNA from human adenovirus type 5","volume":"36","author":"Graham","year":"1977","journal-title":"J Gen Virol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1006\/viro.1997.8597","article-title":"Cloning and sequencing of the cellular-viral junctions from the human adenovirus type 5 transformed 293 cell line","volume":"233","author":"Louis","year":"1997","journal-title":"Virology."},{"key":"B103","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1089\/hum.1996.7.2-215","article-title":"Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors","volume":"7","author":"Fallaux","year":"1996","journal-title":"Hum Gene Ther."},{"key":"B104","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1096\/fj.01-0995fje","article-title":"Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells","volume":"16","author":"Shaw","year":"2002","journal-title":"FASEB J."},{"key":"B105","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/S0958-1669(99)00007-5","article-title":"Adenovirus vectors for gene delivery","volume":"10","author":"Benihoud","year":"1999","journal-title":"Curr Opin Biotechnol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0168-1702(95)00071-2","article-title":"DNA sequence of the deletion\/insertion in early region 3 of Ad5 dl309","volume":"39","author":"Bett","year":"1995","journal-title":"Virus Res."},{"key":"B107","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1006\/mthe.2001.0323","article-title":"Development of a FLP\/frt system for generating helper-dependent adenoviral vectors","volume":"3","author":"Ng","year":"2001","journal-title":"Mol Ther."},{"key":"B108","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1006\/mthe.2002.0532","article-title":"Generation of helper-dependent adenoviral vectors by homologous recombination","volume":"5","author":"Toietta","year":"2002","journal-title":"Mol Ther."},{"key":"B109","doi-asserted-by":"publisher","first-page":"222","DOI":"10.2174\/156652308785160647","article-title":"Advances in helper-dependent adenoviral vector research","volume":"8","author":"Segura","year":"2008","journal-title":"Curr Gene Ther."},{"key":"B110","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1089\/hum.1998.9.18-2709","article-title":"High doses of a helper-dependent adenoviral vector yield supraphysiological levels of \u03b11-antitrypsin with negligible toxicity","volume":"9","author":"Morral","year":"1998","journal-title":"Hum Gene Ther."},{"key":"B111","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1073\/pnas.94.5.1645","article-title":"Persistence in muscle of an adenoviral vector that lacks all viral genes","volume":"94","author":"Chen","year":"1997","journal-title":"Proc Natl Acad Sci USA."},{"key":"B112","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S1040-8428(03)00172-0","article-title":"Immune responses against adenoviral vectors and their transgene products: a review of strategies for evasion","volume":"50","author":"Schagen","year":"2004","journal-title":"Crit Rev Oncol Hematol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0165-2427(00)00217-8","article-title":"The immunogenicity and efficacy of replication-defective and replication-competent bovine adenovirus-3 expressing bovine herpesvirus-1 glycoprotein gD in cattle","volume":"76","author":"Reddy","year":"2000","journal-title":"Vet Immunol Immunopathol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"10200","DOI":"10.1128\/JVI.79.16.10200-10209.2005","article-title":"Replicating rather than nonreplicating adenovirus-human immunodeficiency virus recombinant vaccines are better at eliciting potent cellular immunity and priming high-titer antibodies","volume":"79","author":"Peng","year":"2005","journal-title":"J Virol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"459","DOI":"10.7589\/0090-3558-47.2.459","article-title":"High-density baiting with ONRAB\u00ae rabies vaccine baits to control arctic-variant rabies in striped skunks in Ontario, Canada","volume":"47","author":"Rosatte","year":"2011","journal-title":"J Wildl Dis."},{"key":"B116","doi-asserted-by":"publisher","first-page":"6619","DOI":"10.1016\/j.vaccine.2009.08.005","article-title":"Beresford A. Safety studies on an adenovirus recombinant vaccine for rabies (AdRG13-ONRAB\u00ae) in target and non-target species","volume":"27","author":"Knowles","year":"2009","journal-title":"Vaccine."},{"key":"B117","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1093\/emboj\/20.6.1310","article-title":"Adenovirus-activated PKA and p38\/MAPK pathways boost microtubule-mediated nuclear targeting of virus","volume":"20","author":"Suomalainen","year":"2001","journal-title":"EMBO J."},{"key":"B118","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1128\/JVI.76.4.1559-1568.2002","article-title":"Activation of p38 and ERK signaling during adenovirus vector cell entry lead to expression of the C-X-C chemokine IP-10","volume":"76","author":"Tibbles","year":"2002","journal-title":"J Virol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1002\/jgm.964","article-title":"Adenovirus efficiently transduces plasmacytoid dendritic cells resulting in TLR9-dependent maturation and IFN-\u03b1 production","volume":"8","author":"Basner-Tschakarjan","year":"2006","journal-title":"J Gene Med."},{"key":"B120","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.virusres.2007.10.005","article-title":"Adenovirus vector induced innate immune responses: Impact upon efficacy and toxicity in gene therapy and vaccine applications","volume":"132","author":"Hartman","year":"2008","journal-title":"Virus Res."},{"key":"B121","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2174\/156652307782151452","article-title":"Immune response to helper dependent adenoviral mediated liver gene therapy: challenges and prospects","volume":"7","author":"Seiler","year":"2007","journal-title":"Curr Gene Ther."},{"key":"B122","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/gt.2009.148","article-title":"Progress and prospects: immune responses to viral vectors","volume":"17","author":"Nayak","year":"2010","journal-title":"Gene Ther."},{"key":"B123","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1089\/hum.2008.141","article-title":"Innate immune recognition of viruses and viral vectors","volume":"20","author":"Huang","year":"2009","journal-title":"Hum Gene Ther."},{"key":"B124","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/cmi.12053","article-title":"Adenovirus signalling in entry","volume":"15","author":"Wolfrum","year":"2013","journal-title":"Cell Microbiol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"e1004657","DOI":"10.1371\/journal.ppat.1004657","article-title":"Human adenovirus 52 uses sialic acid-containing glycoproteins and the coxsackie and adenovirus receptor for binding to target cells","volume":"11","author":"Lenman","year":"2015","journal-title":"PLoS Pathog."},{"key":"B126","doi-asserted-by":"publisher","first-page":"E4264","DOI":"10.1073\/pnas.1716900115","article-title":"Polysialic acid is a cellular receptor for human adenovirus 52","volume":"115","author":"Lenman","year":"2018","journal-title":"Proc Natl Acad Sci USA."},{"key":"B127","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1128\/JVI.74.1.42-48.2000","article-title":"Adenovirus type 37 uses sialic acid as a cellular receptor","volume":"74","author":"Arnberg","year":"2000","journal-title":"J Virol."},{"key":"B128","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.virol.2004.04.001","article-title":"Adenovirus type 5 pseudotyped with adenovirus type 37 fiber uses sialic acid as a cellular receptor","volume":"324","author":"Cashman","year":"2004","journal-title":"Virology."},{"key":"B129","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1089\/hum.2007.016","article-title":"Role of MyD88 and TLR9 in the innate immune response elicited by serotype 5 adenoviral vectors","volume":"18","author":"Yamaguchi","year":"2007","journal-title":"Hum Gene Ther."},{"key":"B130","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1128\/JVI.02192-06","article-title":"Innate immune response to adenoviral vectors is mediated by both toll-like receptor-dependent and -independent pathways","volume":"81","author":"Zhu","year":"2007","journal-title":"J Virol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.4049\/jimmunol.181.3.2134","article-title":"Adenovirus vector-induced innate inflammatory mediators, MAPK signaling, as well as adaptive immune responses are dependent upon both TLR2 and TLR9 in vivo","volume":"181","author":"Appledorn","year":"2008","journal-title":"J Immunol"},{"key":"B132","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1128\/JVI.01926-06","article-title":"Preferential activation of toll-like receptor nine by CD46-utilizing adenoviruses","volume":"81","author":"Iacobelli-Martinez","year":"2007","journal-title":"J Virol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"S59","DOI":"10.1016\/j.ymthe.2006.08.171","article-title":"Metabolically biotinylated helper dependent adenovirus: a new and rapid approach for targeting of high-capacity adenoviral vector","volume":"13","author":"Cerullo","year":"2006","journal-title":"Mol Ther."},{"key":"B134","doi-asserted-by":"publisher","first-page":"e1000208","DOI":"10.1371\/journal.ppat.1000208","article-title":"Key role of splenic myeloid DCs in the IFN-\u03b1\u03b2 response to adenoviruses in vivo","volume":"4","author":"Fejer","year":"2008","journal-title":"PLoS Pathog"},{"key":"B135","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1089\/jir.2009.0006","article-title":"Chemokine CXCL1\/KC and its receptor CXCR2 are responsible for neutrophil chemotaxis in adenoviral keratitis","volume":"29","author":"Chintakuntlawar","year":"2009","journal-title":"J Interf Cytokine Res."},{"key":"B136","doi-asserted-by":"publisher","first-page":"e1000841","DOI":"10.1371\/journal.ppat.1000841","article-title":"Viral capsid is a pathogen-associated molecular pattern in adenovirus keratitis","volume":"6","author":"Chintakuntlawar","year":"2010","journal-title":"PLoS Pathog."},{"key":"B137","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.immuni.2009.04.015","article-title":"Virus binding to a plasma membrane receptor triggers interleukin-1\u03b1-mediated proinflammatory macrophage response in vivo","volume":"31","author":"Di Paolo","year":"2009","journal-title":"Immunity"},{"key":"B138","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/mt.2008.307","article-title":"Redundant and synergistic mechanisms control the sequestration of blood-born adenovirus in the liver","volume":"17","author":"Di Paolo","year":"2009","journal-title":"Mol Ther."},{"key":"B139","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/jgm.2705","article-title":"Foamy virus-adenovirus hybrid vectors for gene therapy of the arthritides","volume":"15","author":"Weber","year":"2013","journal-title":"J Gene Med."},{"key":"B140","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.1038\/sj.emboj.7601222","article-title":"Toll-like receptor 3 associates with c-Src tyrosine kinase on endosomes to initiate antiviral signaling","volume":"25","author":"Johnsen","year":"2006","journal-title":"EMBO J."},{"key":"B141","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1038\/mt.2010.124","article-title":"Recognition of virus infection and innate host responses to viral gene therapy vectors","volume":"18","author":"Shayakhmetov","year":"2010","journal-title":"Mol Ther."},{"key":"B142","doi-asserted-by":"publisher","first-page":"6835","DOI":"10.1073\/pnas.0401347101","article-title":"TLR7: A new sensor of viral infection","volume":"101","author":"Crozat","year":"2004","journal-title":"Proc Natl Acad Sci USA."},{"key":"B143","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.coviro.2011.11.004","article-title":"Cytosolic surveillance and antiviral immunity","volume":"1","author":"Rathinam","year":"2011","journal-title":"Curr Opin Virol."},{"key":"B144","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5772\/intechopen.79697","article-title":"Adenoviral vector-based vaccines and gene therapies: current status and future prospects","volume":"4","author":"Singh","year":"2019","journal-title":"IntechOpen."},{"key":"B145","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.virol.2011.02.003","article-title":"Innate immune sensing of DNA viruses","volume":"411","author":"Rathinam","year":"2011","journal-title":"Virology."},{"key":"B146","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1128\/JVI.02702-13","article-title":"Adenovirus detection by the cGAS\/STING\/TBK1 DNA sensing cascade","volume":"88","author":"Lam","year":"2014","journal-title":"J Virol."},{"key":"B147","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1128\/JVI.02134-10","article-title":"The adenovirus E1b55K\/E4orf6 complex induces degradation of the bloom helicase during infection","volume":"85","author":"Orazio","year":"2011","journal-title":"J Virol."},{"key":"B148","doi-asserted-by":"publisher","first-page":"7179","DOI":"10.4049\/jimmunol.174.11.7179","article-title":"Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein","volume":"174","author":"Sumida","year":"2005","journal-title":"J Immunol."},{"key":"B149","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.4049\/jimmunol.1000338","article-title":"CD8 + T cell responses following replication-defective adenovirus serotype 5 immunization are dependent on CD11C + dendritic cells but show redundancy in their requirement of TLR and nucleotide-binding oligomerization domain-like receptor signaling","volume":"185","author":"Lindsay","year":"2010","journal-title":"J Immunol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1172\/JCI78280","article-title":"Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling","volume":"125","author":"Quinn","year":"2015","journal-title":"J Clin Invest."},{"key":"B151","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1128\/JVI.76.6.2667-2675.2002","article-title":"Novel, chimpanzee serotype 68-based adenoviral vaccine carrier for induction of antibodies to a transgene product","volume":"76","author":"Xiang","year":"2002","journal-title":"J Virol."},{"key":"B152","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1189\/jlb.1A0813-451RR","article-title":"The effect of adenovirus-specific antibodies on adenoviral vector-induced, transgene product-specific T cell responses","volume":"96","author":"Small","year":"2014","journal-title":"J Leukoc Biol."},{"key":"B153","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/nature04721","article-title":"Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity","volume":"441","author":"Roberts","year":"2006","journal-title":"Nature."},{"key":"B154","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1089\/104303402320138952","article-title":"The adenovirus capsid protein hexon contains a highly conserved human CD4+ T-cell epitope","volume":"13","author":"Olive","year":"2002","journal-title":"Hum Gene Ther."},{"key":"B155","doi-asserted-by":"publisher","first-page":"6875","DOI":"10.1128\/JVI.72.8.6875-6879.1998","article-title":"Circumvention of immunity to the adenovirus major coat protein hexon","volume":"72","author":"Roy","year":"1998","journal-title":"J Virol."},{"key":"B156","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.virol.2004.12.029","article-title":"Use of chimeric adenoviral vectors to assess capsid neutralization determinants","volume":"333","author":"Roy","year":"2005","journal-title":"Virology."},{"key":"B157","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1128\/jvi.70.3.1836-1844.1996","article-title":"Analysis of 15 adenovirus hexon proteins reveals the location and structure of seven hypervariable regions containing serotype-specific residues","volume":"70","author":"Crawford-Miksza","year":"1996","journal-title":"J Virol."},{"key":"B158","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.1080\/21645515.2017.1383575","article-title":"Chimpanzee adenoviral vectors as vaccines for outbreak pathogens","volume":"13","author":"Ewer","year":"2017","journal-title":"Hum Vaccines Immunother."},{"key":"B159","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1128\/JVI.76.2.841-850.2002","article-title":"Herpes simplex virus type 1 immediate-early protein ICP0 and its isolated RING finger domain act as ubiquitin E3 ligases in vitro","volume":"76","author":"Boutell","year":"2002","journal-title":"J Virol."},{"key":"B160","doi-asserted-by":"publisher","first-page":"115ra2","DOI":"10.1126\/scitranslmed.3002925","article-title":"Vaccine vectors derived from a large collection of simian adenoviruses induce potent cellular immunity across multiple species","volume":"4","author":"Colloca","year":"2012","journal-title":"Sci Transl Med."},{"key":"B161","doi-asserted-by":"publisher","first-page":"e00159","DOI":"10.1128\/JVI.00159-18","article-title":"Immunogenicity and cross-reactivity of rhesus adenoviral vectors","volume":"92","author":"Iampietro","year":"2018","journal-title":"J Virol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1080\/21645515.2017.1419108","article-title":"Development of novel vaccine vectors: chimpanzee adenoviral vectors","volume":"14","author":"Guo","year":"2018","journal-title":"Hum Vaccines Immunother."},{"key":"B163","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41591-020-01194-5","article-title":"T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1\/2 clinical trial","volume":"27","author":"Ewer","year":"2021","journal-title":"Nat Med."},{"key":"B164","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/tbed.12724","article-title":"Safety profile of a replication-deficient human adenovirus-vectored foot-and-mouth disease virus serotype A24 subunit vaccine in cattle","volume":"65","author":"Barrera","year":"2018","journal-title":"Transbound Emerg Dis."},{"key":"B165","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vetimm.2013.05.002","article-title":"Recombinant adenovirus expressing F and H fusion proteins of peste des petits ruminants virus induces both humoral and cell-mediated immune responses in goats","volume":"154","author":"Wang","year":"2013","journal-title":"Vet Immunol Immunopathol."},{"key":"B166","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13567-017-0482-x","article-title":"Vaccination with recombinant adenovirus expressing peste des petits ruminants virus-F or -H proteins elicits T cell responses to epitopes that arises during PPRV infection","volume":"48","author":"Rojas","year":"2017","journal-title":"Vet Res."}],"container-title":["Frontiers in Veterinary Science"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2021.729879\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T08:58:07Z","timestamp":1699433887000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2021.729879\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,8]]},"references-count":166,"alternative-id":["10.3389\/fvets.2021.729879"],"URL":"https:\/\/doi.org\/10.3389\/fvets.2021.729879","relation":{},"ISSN":["2297-1769"],"issn-type":[{"value":"2297-1769","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,8]]},"article-number":"729879"}}